131 related articles for article (PubMed ID: 11147814)
1. G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation.
Ryder NM; Guha S; Hines OJ; Reber HA; Rozengurt E
J Cell Physiol; 2001 Jan; 186(1):53-64. PubMed ID: 11147814
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Guha S; Lunn JA; Santiskulvong C; Rozengurt E
Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
[TBL] [Abstract][Full Text] [Related]
3. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal peptide signalling in health and disease.
Rozengurt E; Guha S; Sinnett-Smith J
Eur J Surg Suppl; 2002; (587):23-38. PubMed ID: 16144198
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin and EGF induce synergistic stimulation of DNA synthesis by increasing the duration of ERK signaling in ductal pancreatic cancer cells.
Kisfalvi K; Guha S; Rozengurt E
J Cell Physiol; 2005 Mar; 202(3):880-90. PubMed ID: 15389644
[TBL] [Abstract][Full Text] [Related]
6. Neurotensin-mediated activation of MAPK pathways and AP-1 binding in the human pancreatic cancer cell line, MIA PaCa-2.
Ehlers RA; Zhang Y; Hellmich MR; Evers BM
Biochem Biophys Res Commun; 2000 Mar; 269(3):704-8. PubMed ID: 10720480
[TBL] [Abstract][Full Text] [Related]
7. Insulin potentiates Ca2+ signaling and phosphatidylinositol 4,5-bisphosphate hydrolysis induced by Gq protein-coupled receptor agonists through an mTOR-dependent pathway.
Kisfalvi K; Rey O; Young SH; Sinnett-Smith J; Rozengurt E
Endocrinology; 2007 Jul; 148(7):3246-57. PubMed ID: 17379645
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1.
Guha S; Rey O; Rozengurt E
Cancer Res; 2002 Mar; 62(6):1632-40. PubMed ID: 11912133
[TBL] [Abstract][Full Text] [Related]
9. Neurotensin receptor-mediated inhibition of pancreatic cancer cell growth by the neurotensin antagonist SR 48692.
Herzig MC; Chapman WG; Sheridan A; Rake JB; Woynarowski JM
Anticancer Res; 1999; 19(1A):213-9. PubMed ID: 10226545
[TBL] [Abstract][Full Text] [Related]
10. PKD, PKD2, and p38 MAPK mediate Hsp27 serine-82 phosphorylation induced by neurotensin in pancreatic cancer PANC-1 cells.
Yuan J; Rozengurt E
J Cell Biochem; 2008 Feb; 103(2):648-62. PubMed ID: 17570131
[TBL] [Abstract][Full Text] [Related]
11. Possible role of duration of PKC-induced ERK activation in the effects of agonists and phorbol esters on DNA synthesis in Panc-1 cells.
Rácz GZ; Szucs A; Szlávik V; Vág J; Burghardt B; Elliott AC; Varga G
J Cell Biochem; 2006 Aug; 98(6):1667-80. PubMed ID: 16637058
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II activates MAP kinase and NF-kappaB through angiotensin II type I receptor in human pancreatic cancer cells.
Amaya K; Ohta T; Kitagawa H; Kayahara M; Takamura H; Fujimura T; Nishimura G; Shimizu K; Miwa K
Int J Oncol; 2004 Oct; 25(4):849-56. PubMed ID: 15375532
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathways for monocyte chemoattractant protein 1-mediated extracellular signal-regulated kinase activation.
Jiménez-Sainz MC; Fast B; Mayor F; Aragay AM
Mol Pharmacol; 2003 Sep; 64(3):773-82. PubMed ID: 12920215
[TBL] [Abstract][Full Text] [Related]
14. Guanosine phosphate binding protein coupled receptors in prostate cancer: a review.
Raj GV; Barki-Harrington L; Kue PF; Daaka Y
J Urol; 2002 Mar; 167(3):1458-63. PubMed ID: 11832770
[TBL] [Abstract][Full Text] [Related]
15. Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer.
Guha S; Eibl G; Kisfalvi K; Fan RS; Burdick M; Reber H; Hines OJ; Strieter R; Rozengurt E
Cancer Res; 2005 Apr; 65(7):2738-45. PubMed ID: 15805273
[TBL] [Abstract][Full Text] [Related]
16. Autocrine and paracrine signaling through neuropeptide receptors in human cancer.
Heasley LE
Oncogene; 2001 Mar; 20(13):1563-9. PubMed ID: 11313903
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1.
Wang JG; Li NN; Li HN; Cui L; Wang P
Neuropeptides; 2011 Apr; 45(2):151-6. PubMed ID: 21272935
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK.
Stähle M; Veit C; Bachfischer U; Schierling K; Skripczynski B; Hall A; Gierschik P; Giehl K
J Cell Sci; 2003 Sep; 116(Pt 18):3835-46. PubMed ID: 12902401
[TBL] [Abstract][Full Text] [Related]
19. Orexin-stimulated MAP kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: diverse roles for orexins A and B.
Ramanjaneya M; Conner AC; Chen J; Kumar P; Brown JE; Jöhren O; Lehnert H; Stanfield PR; Randeva HS
J Endocrinol; 2009 Aug; 202(2):249-61. PubMed ID: 19460850
[TBL] [Abstract][Full Text] [Related]
20. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
